期刊
LEUKEMIA & LYMPHOMA
卷 51, 期 11, 页码 2144-2146出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/10428194.2010.513750
关键词
Antibody-based immunotherapy; Myeloma; Prognostication